MMP1 gene expression enhances myoblast migration and engraftment following implanting into mdx/SCID mice

Cell Adhesion and Migration

Volumn 9, Issue 4, 2015, Pages 283-292

  Pan, Haiying ^a,b   Vojnits, Kinga ^a,b   Liu, Thomas T ^c   Meng, Fanwei ^b   Yang, Lei ^d   Wang, Yigang ^e   Huard, Johnny ^d   Cox, Charles S ^a,b   Lally, Kevin P ^a   Li, Yong ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Southern California Bone and Joint Clinic   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Differentiation; Duchenne muscular dystrophy (DMD); Matrix metalloproteinase (MMP); Mdx mice; Migration; Myoblast transplantation; Skeletal muscle

Indexed keywords

DYSTROPHIN; INTERSTITIAL COLLAGENASE; COLLAGENASE 3; MMP13 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION ASSAY; CELL FUSION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL TRANSPLANTATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENGRAFTMENT; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE STEM CELL; MYOBLAST; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL MOTION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; SCID MOUSE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CELL MOVEMENT; FEMALE; MATRIX METALLOPROTEINASE 13; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, SCID; MYOBLASTS;

EID: 84954227696     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/19336918.2014.983799     Document Type: Article

References (48)

1. Gussoni E, Blau HM, Kunkel LM. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 1997; 3: 970-7; PMID: 9288722; http: //dx. doi. org/10. 1038/nm0997-970
2. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts. Nature 1989; 337: 176-9; PMID: 2643055; http: //dx. doi. org/10. 1038/337176a0
3. Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, Innocenzi A, Mognol P, Thibaud JL, Galvez BG, Barthélémy I, et al. Corrigendum: mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2013; 494: 506; PMID: 23426261; http: // dx. doi. org/10. 1038/nature11976
4. Skuk D, Goulet M, Roy B, Chapdelaine P, Bouchard JP, Roy R, Dugré FJ, Sylvain M, Lachance JG, Deschênes L, et al. Dystrophin expression in muscles of duchenne muscular dystrophy patients after highdensity injections of normal myogenic cells. J Neuropathol Exp Neurol 2006; 65: 371-86; PMID: 16691118; http: //dx. doi. org/10. 1097/01. jnen. 0000218443. 45782. 81
5. Skuk D, Roy B, Goulet M, Chapdelaine P, Bouchard JP, Roy R, Dugré FJ, Lachance JG, Deschênes L, Héléne S, et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 2004; 9: 475-82; PMID: 15038390; http: //dx. doi. org/10. 1016/j. ymthe. 2003. 11. 023
6. Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993; 2: 99-112; PMID: 8143083
7. Bernasconi P, Di Blasi C, Mora M, Morandi L, Galbiati S, Confalonieri P, Cornelio F, Mantegazza R. Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul Disord 1999; 9: 28-33; PMID: 10063832; http: //dx. doi. org/ 10. 1016/S0960-8966(98)00093-5
8. Zanotti S, Saredi S, Ruggieri A, Fabbri M, Blasevich F, Romaggi S, Morandi L, Mora M. Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes. Matrix Biol 2007; 26: 615-24; PMID: 17662584; http: //dx. doi. org/10. 1016/j. matbio. 2007. 06. 004
9. Li Y, Cummins J, Huard J. Muscle injury and repair. Curr Opin Orthop 2001; 12: 409-15; http: //dx. doi. org/10. 1097/00001433-200110000-00008
10. Huard J, Li Y, Fu FH. Muscle injuries and repair: current trends in research. J Bone Joint Surg Am 2002. 84-A: 822-32; PMID: 12004029
11. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 2002; 161: 895-907; PMID: 12213718; http: // dx. doi. org/10. 1016/S0002-9440(10)64250-2
12. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J, Huard J. Transforming growth factorbeta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 2004; 164: 1007-19; PMID: 14982854; http: //dx. doi. org/10. 1016/S0002-9440(10)63188-4
13. Lauer-Fields JL, Juska D, Fields GB. Matrix metalloproteinases and collagen catabolism. Biopolymers 2002; 66: 19-32; PMID: 12228918; http: //dx. doi. org/ 10. 1002/bip. 10201
14. Carmeli E, Moas M, Reznick AZ, Coleman R Matrix metalloproteinases and skeletal muscle: a brief review. Muscle Nerve 2004; 29: 191-7; PMID: 14755482; http: //dx. doi. org/10. 1002/mus. 10529
15. Lehto M, Sims TJ, Bailey AJ Skeletal muscle injury-molecular changes in the collagen during healing. Res Exp Med (Berl) 1985; 185: 95-106; PMID: 3992061; http: //dx. doi. org/10. 1007/BF01854894
16. Bedair H, Liu TT, Kaar JL, Badlani S, Russell AJ, Li Y, Huard J. Matrix metalloproteinase-1 therapy improves muscle healing. J Appl Physiol 2007; 102: 2338-45; PMID: 17551103; http: //dx. doi. org/ 10. 1152/japplphysiol. 00670. 2006
17. Kaar JL, Li Y, Blair HC, Asche G, Koepsel RR, Huard J, Russell AJ. Matrix metalloproteinase-1 treatment of muscle fibrosis. Acta Biomater 2008; 4: 1411-20; PMID: 18440885; http: //dx. doi. org/10. 1016/j. actbio. 2008. 03. 010
18. Wang W, Pan H, Murray K, Jefferson BS, Li Y. Matrix metalloproteinase-1 promotes muscle cell migration and differentiation. Am J Pathol 2009; 174: 541-9; PMID: 19147819; http: //dx. doi. org/10. 2353/ajpath. 2009. 080509
19. Bellayr I, Holden K, Mu X, Pan H, Li Y. Matrix metalloproteinase inhibition negatively affects muscle stem cell behavior. Int J Clin Exp Pathol 2013; 6: 124-41; PMID: 23329998
20. Bellayr I, Mu X, Li Y. Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Med Chem 2009; 1: 1095-111; PMID: 20161478; http: //dx. doi. org/ 10. 4155/fmc. 09. 83
21. Li Y, Pan H, Huard J. Isolating stem cells from soft musculoskeletal tissues. J Vis Exp 2010; PMID: 20644509; http: //dx. doi. org/10. 3791/2011
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8; PMID: 11846609; http: //dx. doi. org/ 10. 1006/meth. 2001. 1262
23. Li Y, Li J, Zhu J, Sun B, Branca M, Tang Y, Foster W, Xiao X, Huard J. Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther 2007; 15: 1616-22; PMID: 17609657; http: //dx. doi. org/10. 1038/sj. mt. 6300250
24. Deasy BM, Feduska JM, Payne TR, Li Y, Ambrosio F, Huard J. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther 2009; 17: 1788-98; PMID: 19603004; http: //dx. doi. org/10. 1038/mt. 2009. 136
25. Bachrach E, Perez AL, Choi YH, Illigens BM, Jun SJ, del Nido P, McGowan FX, Li S, Flint A, Chamberlain J, et al. Muscle engraftment of myogenic progenitor cells following intraarterial transplantation. Muscle Nerve 2006; 34: 44-52; PMID: 16634061; http: //dx. doi. org/10. 1002/mus. 20560
26. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401: 390-4; PMID: 10517639
27. Townsend D, Blankinship MJ, Allen JM, Gregorevic P, Chamberlain JS, Metzger JM. Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. Mol Ther 2007; 15: 1086-92; PMID: 17440445
28. Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA, Davies KE. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 1991; 352: 815-8; PMID: 1881437; http: //dx. doi. org/ 10. 1038/352815a0
29. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-28; PMID: 3319190; http: //dx. doi. org/10. 1016/0092-8674(87)90579-4
30. Watt DJ, Lambert K, Morgan JE, Partridge TA, Sloper JC. Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J Neurol Sci 1982; 57: 319-31; PMID: 6761411; http: // dx. doi. org/10. 1016/0022-510X(82)90038-7
31. Partridge TA. Stem cell route to neuromuscular therapies. Muscle Nerve 2003; 27: 133-41; PMID: 12548520; http: //dx. doi. org/10. 1002/mus. 10243
32. Skuk D. Myoblast transplantation for inherited myopathies: a clinical approach. Expert Opin Biol Ther 2004; 4: 1871-85; PMID: 15571450; http: //dx. doi. org/ 10. 1517/14712598. 4. 12. 1871
33. Partridge TA. Invited review: myoblast transfer: a possible therapy for inherited myopathies? Muscle Nerve 1991; 14: 197-212; PMID: 2041542; http: //dx. doi. org/ 10. 1002/mus. 880140302
34. Nicholson LV, Johnson MA, Gardner-Medwin D, Bhattacharya S, Harris JB. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (Berl) 1990; 80: 239-50; PMID: 2205076; http: //dx. doi. org/ 10. 1007/BF00294640
35. Mills P, Lafreniere JF, Benabdallah BF, El Fahime EM, Tremblay JP. A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor. Exp Cell Res 2006; 313: 527-37; PMID: 17156777
36. Caron NJ, Asselin I, Morel G, Tremblay JP. Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant 1999; 8: 465-76; PMID: 10580341
37. Fan Y, Maley M, Beilharz M, Grounds M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 1996; 19: 853-60; PMID: 8965839; http: //dx. doi. org/10. 1002/(SICI)1097-4598(199607) 19: 7%3c853:: AID-MUS7%3e3. 0. CO; 2-8
38. Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 1995; 333: 832-8; PMID: 7651473; http: //dx. doi. org/10. 1056/NEJM 199509283331303
39. Karpati G, Holland P, Worton RG. Myoblast transfer in DMD: problems in the interpretation of efficiency. Muscle Nerve 1992; 15: 1209-10; PMID: 1406777; http: //dx. doi. org/10. 1002/mus. 880151016
40. Listrat A, Picard B, Geay Y. Age-related changes and location of type I, III and IV collagens during skeletal muscle development of double-muscled and normal bovine foetuses. J Muscle Res Cell Motil 1998; 19: 1-14; PMID: 9477372; http: //dx. doi. org/10. 1023/ A: 1005305824838
41. Ozawa J, Kurose T, Kawamata S, Kaneguchi A, Moriyama H, Kito N. Regulation of connective tissue remodeling in the early phase of denervation in a rat skeletal muscle. Biomed Res 2013; 34: 251-8; PMID: 24190237; http: //dx. doi. org/10. 2220/biomedres. 34. 251
42. Ahtikoski AM, Koskinen SO, Virtanen P, Kovanen V, Risteli J, Takala TE. Synthesis and degradation of type IV collagen in rat skeletal muscle during immobilization in shortened and lengthened positions. Acta Physiol Scand 2003; 177: 473-81; PMID: 12648165; http: // dx. doi. org/10. 1046/j. 1365-201X. 2003. 01061. x
43. El Fahime E, Torrente Y, Caron NJ, Bresolin MD, Tremblay JP. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res 2000; 258: 279-87; PMID: 10896779; http: // dx. doi. org/10. 1006/excr. 2000. 4962
44. Lafreniere JF, Mills P, Tremblay JP, El Fahime E. Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity. Transplantation 2004; 77: 1741-7; PMID: 15201676; http: //dx. doi. org/ 10. 1097/01. TP. 0000131175. 60047. EB
45. Morgan J, Rouche A, Bausero P, Houssaini A, Gross J, Fiszman MY, Alameddine HS. MMP-9 overexpression improves myogenic cell migration and engraftment. Muscle Nerve 2010; 42: 584-5; PMID: 20734311; http: //dx. doi. org/10. 1002/mus. 21737
46. Zimowska M, Olszynski KH, Swierczynska M, Streminska W, Ciemerych MA. Decrease of MMP-9 activity improves soleus muscle regeneration. Tissue Eng Part A 2012; 18: 1183-92; PMID: 22429194; http: //dx. doi. org/10. 1089/ten. tea. 2011. 0459
47. Mu X, Urso ML, Murray K, Fu F, Li Y. Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice. Am J Pathol 2010; 177: 2399-410; PMID: 20934971; http: //dx. doi. org/10. 2353/ajpath. 2010. 091121
48. Mu X, Bellayr I, Pan H, Choi Y, Li Y. Regeneration of soft tissues is promoted by MMP1 treatment after digit amputation in mice. PLoS One 2013; 8: e59105; PMID: 23527099; http: //dx. doi. org/10. 1371/journal. pone. 0059105